kathleen m. macqueen, ph · 2016-09-29 · 2001-2002 hiv, std, and tb public health ethics,...

15
Kate MacQueen, PhD Page 1 Last Rev: 27 September 2016 Kathleen M. MacQueen, Ph.D Summary of Professional Experience Kathleen MacQueen is a Senior Scientist in Social and Behavioral Health Sciences at FHI 360. She provides leadership in the development, implementation and management of research projects that integrate qualitative and quantitative methodologies and conducts formative, participatory, and ethics-oriented research related to clinical trials, with a focus on biomedical interventions to prevent HIV transmission. Prior to joining FHI 360, Dr. MacQueen worked at the Centers for Disease Control and Prevention (CDC) for ten years. For her last two years at the CDC, Dr. MacQueen held the position of Deputy Associate Director for Science, Office of the Director, National Center for HIV, STD, and TB Prevention. She received her Ph.D. in Anthropology from Binghamton University and her M.P.H. from Emory University. Education M.P.H., Emory University School of Public Health, Atlanta, GA, 1993 Ph.D., Anthropology, Binghamton University, NY, 1989 M.A., Anthropology, Binghamton University, NY, 1981 B.A., Anthropology, Miami University, Ohio, 1978 Professional Experience 2001 to Present Senior Social Scientist, FHI 360, Durham, NC 2005 to 2013 Coordinator of Interdisciplinary Research Ethics, Office of International Research Ethics, FHI 360, Durham, NC 2012 to Present Adjunct Associate Professor, Health Behavior, School of Public Health, University of North Carolina at Chapel Hill 2003 to 2011 Adjunct Assistant Professor, Health Behavior and Health Education, School of Public Health, University of North Carolina at Chapel Hill 2006 to Present Adjunct Associate Professor, Department of Social Medicine, School of Medicine, University of North Carolina at Chapel Hill 1999 to 2001 Deputy Associate Director for Science, Office of the Director, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA

Upload: others

Post on 26-Apr-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen, PhD Page 1 Last Rev: 27 September 2016

Kathleen M. MacQueen, Ph.D

Summary of Professional Experience

Kathleen MacQueen is a Senior Scientist in Social and Behavioral Health Sciences at FHI 360. She

provides leadership in the development, implementation and management of research projects that integrate

qualitative and quantitative methodologies and conducts formative, participatory, and ethics-oriented research

related to clinical trials, with a focus on biomedical interventions to prevent HIV transmission. Prior to joining

FHI 360, Dr. MacQueen worked at the Centers for Disease Control and Prevention (CDC) for ten years. For

her last two years at the CDC, Dr. MacQueen held the position of Deputy Associate Director for Science,

Office of the Director, National Center for HIV, STD, and TB Prevention. She received her Ph.D. in

Anthropology from Binghamton University and her M.P.H. from Emory University.

Education

M.P.H., Emory University School of Public Health, Atlanta, GA, 1993

Ph.D., Anthropology, Binghamton University, NY, 1989

M.A., Anthropology, Binghamton University, NY, 1981

B.A., Anthropology, Miami University, Ohio, 1978

Professional Experience

2001 to Present Senior Social Scientist, FHI 360, Durham, NC

2005 to 2013 Coordinator of Interdisciplinary Research Ethics, Office of International

Research Ethics, FHI 360, Durham, NC

2012 to Present Adjunct Associate Professor, Health Behavior, School of Public Health,

University of North Carolina at Chapel Hill

2003 to 2011 Adjunct Assistant Professor, Health Behavior and Health Education,

School of Public Health, University of North Carolina at Chapel Hill

2006 to Present Adjunct Associate Professor, Department of Social Medicine, School of

Medicine, University of North Carolina at Chapel Hill

1999 to 2001 Deputy Associate Director for Science, Office of the Director, National

Center for HIV, STD, and TB Prevention, Centers for Disease Control

and Prevention, Atlanta, GA

Page 2: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen, PhD Page 2 Last Rev: 27 September 2016

1992 to 1999 Research Anthropologist, Epidemiology Branch, Division of HIV/AIDS

Prevention, National Center for HIV, STD and TB Prevention, Centers

for Disease Control and Prevention, Atlanta GA

1991 to 1992 Post-Doctoral Fellow, HIV/AIDS Training Program for Behavioral and

Social Scientists, Emory University School of Public Health and the

Division of HIV/AIDS, National Center for Infectious Diseases, Centers

for Disease Control, Atlanta GA

1989 to 1991 Visiting Assistant Professor, Department of Anthropology and

Linguistics, University of Georgia

Major Activities 2016-2021 Coalition to Accelerate and Support Prevention Research (CASPR) (FHI 360 sub-

agreement to AVAC USAID Cooperative Agreement AID-OAA-A-16-00031. Role: FHI

360 Sub-project lead)

2015-2021 University of North Carolina at Chapel Hill Center for AIDS Research (NIH P30

AI50410. Role: Developmental Core Director)

2013-2016 Adherence Measurement and Optimization of Long-Acting ARV-Based Vaginal Rings

(USAID funding, Cooperative Agreement AID-OAA-A-14-00003. Role: Project lead/PI)

2013-2015 Developing a Theory of Change for Evaluating Participatory Practices in TB Trials

(NIAID/NIH R21AI108519. Role: PI)

2013-2014 Piloting an Organizational Network-Building tool to Assess HIV Service Linkages in

Durham, North Carolina. (UNC CFAR Developmental Award. Role: co-PI)

2012-2014 CAPRISA 106 Tenofovir Gel Social and Health Systems Research Study (USAID funding.

Role: Project lead and Co-PI)

2011-ongoing HPTN 069 Phase II Randomized, Double-Blind, Controlled Study of the Safety,

Tolerability, and Adherence of Maraviroc, Maraviroc + Emtricitabine, or

Tenofovir/Emtricitabine for Pre-Exposure Prophylaxis (PrEP) To Prevent HIV in At-Risk

Men Who Have Sex with Men (NIAID/NIH HIV Prevention Trials Network funding. Role:

Protocol Team, Ethics Working Group Representative)

2009-2011 Gender and Multiple and Concurrent Sexual Partnerships in Zambia (Jointly funded by

the National AIDS Commission Zambia, United Nations, and USAID. Role: Scientific

Lead)

2008-2013 HPTN 061 Feasibility of a community-level, multi-component intervention for Black MSM

in preparation for a Phase IIB community-level randomized trial to test the efficacy of the

intervention in reducing HIV incidence among Black MSM (NIAID/NIH HIV Prevention

Page 3: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen, PhD Page 3 Last Rev: 27 September 2016

Trials Network funding. Role: Protocol Team, Ethics Working Group Representative)

2008-2013 A Partnership Initiative for HIV Prevention Trials (LinCS 2 Durham) (NINR/NIH

1R01NR011232. Role: PI)

2007-2014 Stakeholder Toolkit for Community Engagement (USAID funding. Role: Project lead)

2007-2008 Gender and Multiple and Concurrent Sexual Partnerships in Lesotho (Jointly funded by

UNAIDS and USAID; collaboratively led with National AIDS Commission Lesotho and

UNAIDS. Role: Scientific lead)

2007-2013 CAPRISA 104: Microbicide Case Control Study to Evaluate Behavioural

Patterns of Risk and Gel Use in a Phase 2b Trial (USAID funding. Role: PI)

2007-2013 Evaluating Informed Consent Comprehension (USAID funding. Role: Co-Investigator)

2007 Measuring Disinhibition in HIV Vaccine Trials (Merck funding. Role: Project lead)

2006-2010 CAPRISA 004 Phase IIb Trial to Assess the Safety and Effectiveness of the Vaginal

Microbicide 1% Tenofovir Gel for the Prevention of HIV Infection in women in South

Africa (USAID funding. Role: Behavioral technical assistance)

2006-2009 Site Identification and Development Initiative (USAID funding. Role: Behavioral Lead)

2004-2006 HIV Prevention Trials Network Partnering for Care Project. (NIAID/NIH HIV

Prevention Trials Network funding. Role: Protocol chair)

2002-2007 Formative Research for a Phase 2b Preventive HIV Intervention Trial with Tenofovir in

Africa. (Bill and Melinda Gates Foundation funding. Role: Lead investigator)

2002-2004 Evaluation of Standard of Care in Research Settings: A Preparedness Study for HPTN

Protocol 035. (NIAID/NIH HIV Prevention Trials Network funding. Role: Project lead)

2002-2003 HIV Prevention Trials Network Ethical Guidance for Research. (NIAID/NIH HIV

Prevention Trials Network funding. Role: Project lead)

2002 Capacity Building and Technical Assistance in Qualitative Research. (USAID funding.

Role: Project lead)

2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case

Study Review. (CDC project lead)

1999 Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug

Users in Bangkok, Thailand. (Bangkok Metropolitan Administration, VaxGen Inc.,

Mahidol University, HIV/AIDS Collaboration, and CDC. Role: CDC Behavioral lead).

Page 4: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen, PhD Page 4 Last Rev: 27 September 2016

1998-1999 Conduct and Evaluation of On-going Phase III HIV Vaccine Efficacy Trials in the U.S.:

Social and Behavioral Research (CDC project lead)

1997 Building Community Partnership in Health Research. (CDC project lead)

1996-1998 Assessment of Willingness to Participate in a Prospective HIV Vaccine Efficacy Trial

among Injecting Drug Users in Bangkok, Thailand. (CDC PI )

1995-1998 Project LinCS: Linking Communities and Scientists. (CDC project director)

1993-2001 AnSWR (Analysis Software for Word-based Records) (CDC project collaborator).

1992-1994 CDC Collaborative HIV Seroincidence Study. (CDC project director)

1992-1994 Belle Glade Project: Ethnographic Research. (CDC project director)

Publications

Peer-Reviewed Articles

2016 MacQueen KM, Eley NT, Frick M, Mingote LR, Chou A, Seidel S, Hannah S, Hamilton C.

Developing a framework for evaluating ethical outcomes of Good Participatory Practices in TB

Clinical Drug Trials. Journal of empirical research on human research ethics: JERHRE 11:203-

213. doi:10.1177/1556264616657452

2016 MacQueen KM, Warren M. HIV Vaccine Awareness Day: sustaining the momentum. Journal of

the International AIDS Society 19:21202. doi.org/10.7448/IAS.19.1.21202

2016 Stalter RM, Moench TR, MacQueen KM, Tolley EE, Owen DH. Biomarkers and biometric

measures of adherence to use of ARV-based vaginal rings. Journal of the International AIDS

Society 19:20746 doi.org/10.7448/IAS.19.1.20746

2016 Jolly DH, Mueller MP, Chen M, Alston L, Hawley M, Okumu E, Eley NT, Stancil T, MacQueen

KM. Concurrency and other sexual risk behaviors among Black young adults in a southeastern

city. AIDS Educ Prev 2016; 28(1):59–76

2016 MacQueen KM, Dlamini S, Perry B, Okumu E, Sortijas S, Singh C, Pillay D, Majors A, Jerome

S, Watson S, Abdool Karim S, Abdool Karim Q, Mansoor LE. Social context of adherence in an

open-label 1% Tenofovir Gel trial: gender dynamics and disclosure in KwaZulu-Natal, South

Africa. AIDS Behav (published online 015 March 2016). doi: 10.1007/s10461-016-1339-4

2015 MacQueen KM, Bahn A, Frohlich J, Holzer J, Sugarman J., Ethics Working Group of the HIV

Prevention Trials Network. Evaluating community engagement in global health research: the need

Page 5: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 5 Last Rev: 27 September 2016

for metrics. BMC Med Ethics. 16(1):44. doi: 10.1186/s12910-015-0033-9. PubMed PMID:

26126899.

2015 MacQueen KM, Chen M, Jolly D, Mueller MP, Okumu E, Eley NT, Laws M, Isler MR, Kalloo

A, Rogers RC. HIV testing experience and risk behavior among sexually active Black young

adults: a CBPR-based study using respondent-driven sampling in Durham, North Carolina.

American Journal of Community Psychology 55(3):433-443. doi:10.1007/s10464-015-9725-z

2014 Isler MR, Brown A, Eley N, Mathews A, Batten K, Rogers R, Powell N, White C, Underwood R,

MacQueen K. Curriculum Development to Increase Minority Research Literacy for HIV

Prevention. Progress in Community Health Partnerships 8.4:511-521.

2014 Succop S, MacQueen KM; van Loggerenberg F; Majola N; Abdool Karim Q; Abdool Karim SS.

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS

Care: Psychological and Socio-medical Aspects of AIDS/HIV 26:12:521-1525. doi:

10.1080/09540121.2014.938014

2014 Headley J, Lemons A, Corneli A, Agot K, Ahmed K, Wang M, Odhiambo J, Skhosana J,

Tharaldson J, Van Damme L, MacQueen KM. The Sexual Risk Context among the FEM-PrEP

Study Population in Bondo, Kenya and Pretoria, South Africa. PLoS ONE 9(9): e106410.

doi:10.1371/journal.pone.0106410

2014 MacQueen KM, Tolley EE, Owen D, Amico KR, Morrow KM, Moench T, Friend D, Friedland

B. An interdisciplinary framework for measuring and supporting adherence in HIV prevention

trials of ARV-based vaginal rings. Journal of the International AIDS Society 17(Suppl 2):e19158.

http://dx.doi.org/10.7448/IAS.17.3.19158

2014 MacQueen KM, Chen M, Ramirez C, Nnko SEA, Earp KM. Comparison of closed-ended, open-

ended, and perceived informed consent comprehension measures for a mock HIV prevention trial

among women in Tanzania. PLoS ONE 9(8): e105720. doi:10.1371/journal.pone.0105720

2014 MacQueen KM, Weaver MA, van Loggerenberg F, Succop S, Majola N, Taylor D, Abdool

Karim Q, Abdool Karim S. “Assessing Adherence in the CAPRISA 004 Tenofovir Gel HIV

Prevention Trial: Results of a Nested Case–Control Study.” AIDS and Behavior 18(5):826-832

2014 Mansoor LE, Abdool Karim Q, Yende-Zuma N, MacQueen KM, Baxter C, Madlala BT, Grobler

A, Abdool Karim SS. “Adherence in the CAPRISA 004 Tenofovir Gel Microbicide Trial.” AIDS

and Behavior 18(5):811-819

2014 Mansoor LE, Abdool Karim Q, Werner L, Madlala B, Ngcobo N, Cornman DH, Amico KR,

Fisher J, Fisher WA, MacQueen KM, Abdool Karim SS. “Impact of an Adherence Intervention

on the Effectiveness of Tenofovir Gel in the CAPRISA 004 Trial.” AIDS and Behavior 18(5):

841-848.

2013 Crockett K, O’Shea J, Buckingham F, MacQueen K, Chen M, Simpson K. “FATHOMing Out

Interdisciplinary Research Transfer.” 2013 Institute of Electrical and Electronics Engineers (IEEE)

Symposium Series on Computational Intelligence (SSCI), Singapore, Conference Proceedings, pp

Page 6: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 6 Last Rev: 27 September 2016

84 – 90. DOI: 10.1109/CIES.2013.6611733

2013 Woodsong C; MacQueen K; Amico R; Friedland B; Gafos M; Mansoor L; Tolley E; McCormack

S. “Microbicide clinical trial adherence: insights for introduction.” Journal of the International

AIDS Society 16:18505

2011 MacQueen KM. Framing the social in biomedical HIV prevention trials : a 20-year retrospective.

Journal of the International AIDS Society 14(Suppl 2) :S3.

http://www.jiasociety.org/content/14/S2/S3

2010 Mack N, Robinson ET, MacQueen KM, Moffett J, Johnson LM. The exploitation of

“exploitation” in the Tenofovir PrEP Trial in Cameroon: lessons learned from media coverage of

an HIV prevention trial. Journal of Empirical Research on Human Research Ethics 5(2):3-19.

2010 Guest GG, Shattuck D, Johnson L, Akumatey B, Clarke EEK, Chen P-L, MacQueen KM.

Acceptability of PrEP for HIV prevention among women at high risk for HIV. Journal of

Women’s Health 19(4):1-8.

2008 MacQueen KM, McLoughlin K, Alleman P, Burke HM, Mack N. Partnering for care in HIV

prevention trials. Journal of Empirical Research on Human Research Ethics 3(4):5-18.

2008 Guest GG, Shattuck D, Johnson L, Akumatey B, Clarke EEK, Chen P-L, MacQueen KM.

Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial. STD

35(12):1002-8.

2008 Karp DR, Carlin S, Cook-Deegan R, Ford DE, Geller G, Glass DN, Greely H, Guthridge, Kahn J,

Kaslow R, Kraft C, MacQueen K, Malin B, Scheuerman RH, Sugarman J.

Ethical and Practical Issues Associated with Aggregating Databases. PLoS Medicine

5(9):e190.doi:10.1371/journal.pmed.0050190

2008 MacQueen KM, Alleman P. “International perspectives on the collection, storage, and testing of

human biospecimens in HIV research.” IRB Ethics & Human Research 30(4):9-14.

2007 MacQueen KM, Johnson L, Alleman P, Akumatey B, Lawoyin T, Nyiama T. “Pregnancy

prevention practices among women with multiple partners in a HIV prevention trial.” JAIDS

46(1):32-38.

2007 MacQueen KM, Namey E, Chilongozi DA, Mtweve SP, Mlingo M, Morar N, Reid C, Ristow A,

Sahay S, HPTN 035 Standard of Care Assessment Team. “Community perspectives on care

options for HIV prevention trial participants.” AIDS Care Journal 19(4):554-560.

2007 MacQueen KM, Abdool Karim Q. “Adolescents and HIV clinical trials: ethics, culture, and

context.” The Journal of the Association of Nurses in AIDS Care (JANAC) 18(2):78-82.

2006 Kegeles SM, Johnson MO, Strauss RP, Ralston B, Hays RB, Metzger DS, McLellan-Lemal E,

MacQueen KM. “How should HIV vaccine efficacy trials be conducted? Diverse U.S.

Communities Speak Out.” AIDS Education and Prevention 18(6):560-572.

Page 7: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 7 Last Rev: 27 September 2016

2006 Woodsong C, MacQueen KM, Namey E, Sahay S, Mlingo M, Morrar N, Mehendele S.

“Women’s autonomy and informed consent in international microbicide clinical trials.” Journal of

Empirical Research on Human Research Ethics (JERHRE) 1(3):11-26.

2005 Grant RM, Buchbinder S, Cates W Jr, Clarke E, Coates T, Cohen MS, Delaney M, Flores G,

Goicochea P, Gonsalves G, Harrington M, Lama J, MacQueen KM, Moore JP, Peterson L,

Sanchez J, Thompson M, Wainberg MA. “Promote HIV chemoprophylaxis research, don’t

prevent it.” Science 309:2170-1.

2005 MacQueen KM, Cates W Jr., “The multiple layers of prevention-science research.” American

Journal of Preventive Medicine, 28(5):491-5.

2004 Vanable PA, McKirnan DJ, Buchbinder SP, Bartholow BN, Douglas JM, Judson FN, MacQueen

KM. “Alcohol use and high-risk sexual behavior among men who have sex with men: the effects

of consumption level and partner type.” Health Psychology 23(5):525-532

2004 MacQueen KM, Buehler JW. “Ethics, practice, and research in public health: a case-based

review.” AJPH 94(6):929-932

2004 MacQueen KM, Shapiro K, Abdool Karim Q, Sugarman J. “Ethical challenges in international

HIV prevention research.” Accountability in Research 11:49-61

2003 MacQueen KM, Abdool Karim Q, Sugarman J on behalf of the HPTN Ethics Working Group.

“Ethics guidance for HIV prevention trials. BMJ 327:340

2003 MacQueen KM, Sugarman J. “Back to the rough ground: working in international HIV

prevention research as ethical debates continue.” IRB: Ethics and Human Research 25(2):11-13

2003 McLellan E, MacQueen KM, Niedig J. “Beyond the qualitative interview: data preparation and

transcription.” Field Methods 15(1):63-84

2001 MacQueen KM, McLellan E, Metzger DS, Kegeles S, Strauss RP, Scotti R, Blanchard L, Trotter

RT. “What is community? An evidence-based definition for participatory public health.” AJPH

91:1929-1938

2001 Strauss RP, Sengupta S, Kegeles S, McLellan E, Metzger D, Eyre S, Khanani F, Emrick CB,

MacQueen KM. “Willingness to volunteer in future preventive HIV vaccine trials: Issues and

perspectives from three U.S. communities. JAIDS 26:63-71

1999 MacQueen KM, Vanishseni S, Kitayaporn D, Lin LS, Buavirat A, Naiwatanakul T, Raktham S,

Mock P, Heyward WL, Des Jarlais DC, Choopanya K, Mastro T. “Willingness of Injection Drug

Users to Participate in an HIV Vaccine Efficacy Trial in Bangkok, Thailand.” JAIDS 21:243-251

1999 MacQueen KM, Milstein B. “A Systems Approach to Qualitative Data Management and

Analysis.” Field Methods 11:27-39

Page 8: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 8 Last Rev: 27 September 2016

1999 Scheer S, Douglas JM, Vittinghoff E, Bartholow BN, McKirnan D, Judson FN, MacQueen KM,

Buchbinder S. “The feasibility and suitability of targeting young gay men for HIV vaccine trials.”

J AIDS & Human Retrovirology 20:172-178

1999 Vittinghoff E, Buchbinder SP, Douglas J, Judson F, McKirnan D, MacQueen KM. “Per-contact

risk of HIV transmission between male sexual partners: results from the CDC Collaborative HIV

Seroincidence Study.” American Journal of Epidemiology 150:306-311

1998 Heyward WL, MacQueen KM, Goldenthal KL. “HIV Vaccine Development and Evaluation:

Realistic Expectations.” AIDS Research and Human Retroviruses 14(Suppl 3):S-205--S-210

1998 MacQueen KM, McLellan E, Kay K, Milstein B. “Codebook Development for Team-Based

Qualitative Analysis.” Cultural Anthropology Methods 10(2):31-36

1997 Bartholow BN, MacQueen KM, McKirnan DJ, Buchbinder S, Judson F. “The Dynamic Decision

to Participate in HIV Vaccine Efficacy Trials: An Assessment of Willingness Among Homosexual

and Bisexual Men At-Risk of HIV Infection.” AIDS Research and Human Retroviruses 16:108-

115

1997 Heyward WL, MacQueen KM, Jaffe HW. “Obstacles and Progress Toward Development of a

Preventive HIV Vaccine.” Journal of the International Association of Physicians in AIDS Care

3(8):28-34.

1996 MacQueen KM, Nopkesorn T, Sweat MD, Sawaengdee Y, Mastro TD, Weniger BG . "Alcohol

Consumption, Brothel Attendance, and Condom Use: Normative Expectations among Thai

Military Conscripts." Medical Anthropology Quarterly 10(3):402-423

1996 MacQueen KM, S Buchbinder, J Douglas, F Judson, DJ McKirnan, B Bartholow. "Required HIV

Antibody Testing, Social Risk, and HIV Vaccine Efficacy Trials." AIDS and Public Policy

Journal 11(2):87-95

1996 Hennessy M, MacQueen KM, McKirnan DJ, Buchbinder S, Judson F, Douglas J, Bartholow B,

Sheon A. "A Factorial Survey Study to Assess the Acceptability of HIV Vaccine Trial Designs."

Controlled Clinical Trials 17(3):209-220

1996 Buchbinder S, Judson F, McKirnan D, Bartholow B, Douglas J, Katz M, MacQueen KM.

"Feasibility of Human Immunodeficiency Virus Vaccine Trials in Homosexual Men in the U.S.:

Risk Behavior, Seroincidence and Willingness to Participate." Journal of Infectious Diseases

174:954-61

1995 Hennessy M, MacQueen KM, Seals B. "Using Factorial Surveys for Designing Intervention

Programs." Evaluation Review 19(3):294-312

1995 Sweat MD, Nopkesorn T, Mastro TD, Sangkharomya S, MacQueen K, Pokapanichwong W,

Swawengdee Y, Weniger BG. “AIDS Awareness Among a Cohort of Young Thai Men: Exposure

to Information, Level of Knowledge, and Perception of Risk.” AIDS Care 7(5):573-591

Page 9: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 9 Last Rev: 27 September 2016

1994 MacQueen KM. "The Epidemiology of HIV Transmission: Trends, Structure and Dynamics."

Annual Review of Anthropology 23:509-26

1994 MacQueen KM, Buchbinder S, Douglas JM, Judson FN, McKirnan DJ, Bartholow B. "The

decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk

for HIV infection." AIDS Research and Human Retroviruses 10(suppl 2):s261-s264

1984 MacQueen KM, Leslie PW. "Patterns of supplementation, nursing behavior, and lactation: a

simulation analysis." Medical Anthropology 8:274-291

Books, Reports, and Chapters

2014 Tolley E, Friedland B, Gafos M, Amico R, Van Damme L, Woodsong C, MacQueen K, Mansoor

L, McCormack S. Chapter 16: Socioeconomic and Behavioral Factors Influencing Choice,

Adherence, and Success of Microbicide Formulations. IN: Sarmento B, das Neves J, editors. Drug

Delivery and Development of Anti-HIV Microbicides. Pan Stanford Publishing.

2011 Guest G, MacQueen KM, Namey E. Applied Thematic Analysis. Thousand Oaks, CA: SAGE

Publications.

2008 MacQueen KM, May M. Partnering for Care in HIV Prevention Trials: A How-To Manual.

Research Triangle Park, NC: Family Health International.

2007 Guest G, MacQueen KM, editors. Handbook for Team-Based Qualitative Research. Berkeley

CA: Altamira Press. Authored Chapters:

MacQueen KM, Guest G. Chapter 1. An introduction to team-based qualitative research.

MacQueen KM. Chapter 2. Ethics and team-based research.

MacQueen KM, McLellan-Lemal E, Bartholow K, Milstein B. Chapter 6. Codebook development

for team-based qualitative research.

Guest G, Namey E, MacQueen KM. Chapter 9. A framework for monitoring sociobehavioral

research.

Guest G, MacQueen KM. Chapter 10. Re-evaluating guidelines in qualitative research.

Peer-reviewed Abstract Presentations

2014 MacQueen KM, Dlamini S, Perry B, Majors A, Singh C, Pillay D, Okumu E, Watson S. “Gel

Use Disclosure in an Open-label 1% Tenofovir Gel Trial: Perspectives from Participants, Partners

and Community Men in KwaZulu-Natal, South Africa.” Oral Presentation at HIV Research for

Prevention, Cape Town, South Africa, October 28-31, 2014, Abstract OA02.03.

2014 MacQueen KM, Dlamini S, Perry B, Okumu E, Sortijas S, Singh C, Pillay D, Watson S.

“Tenofovir gel as a component of the HIV prevention mix: perspectives from participants, partners

and community men in KwaZulu-Natal, South Africa.” Poster presentation at HIV Research for

Prevention, Cape Town, South Africa, October 28-31, 2014, Abstract P50.03.

2013 Jolly D, Okumu E, Hawley M, Mueller M, Eley N, Stancil T, Alston L, Black A, Roman Isler M,

Page 10: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 10 Last Rev: 27 September 2016

Chen M, MacQueen K. “Concurrency and other sexual risks among black young adults in the

Southeast U.S.” Poster presentation at APHA, Boston, MA, November 2 - 6, 2013.

2012 MacQueen, Kathleen M.; Chen, Mario; Jolly, David H.; Mueller, Monique P.; Okumu, Eunice;

Hawley, Marcus H.; Horne, Alexandria; Eley, Natalie T. “Willingness of Black young adults to

participate in biomedical HIV prevention trials in Durham, North Carolina.” Poster presented at

AIDS 2012 (XIX International AIDS Conference), Washington, DC, July 22-27, Poster TUPE171.

http://pag.aids2012.org/abstracts.aspx?aid=10059

2012 MacQueen, Kathleen M.; Chen, Mario; Jolly, David H.; Mueller, Monique P.; Okumu, Eunice;

Hawley, Marcus H.; Horne, Alexandria; Eley, Natalie T. “HIV testing experience among black

young adults in Durham, North Carolina.” Poster presented at AIDS 2012 (XIX International

AIDS Conference), Washington, DC, July 22-27, Poster THPE583.

http://pag.aids2012.org/abstracts.aspx?aid=10106

2011 MacQueen K, Costenbader E. “Sexual concurrency: modeling, measuring, meaning.” Oral

presentation at Locating the Social: 1st International HIV Social Science and Humanities

Conference, Durban, South Africa, 11-13 June.

2011 Jolly D, Parker C, Mathews A, Mueller M, Reed C, Gibson-Hooks K, Horne A, Rogers R,

MacQueen K. “Sexual behaviors among Black young adults: Gathering sensitive information in

focus groups.” Oral presentation at APHA, Washington, DC, October 29 - November 2.

2010 Chirwa B, Mulenga M, Gillespie A, MacQueen K, Ongina J, Ramirez C, Mulenga O, Khondowe

S, Gboun M, Witola H, Myint S, Barwise K, Mulenga F, Sunkutu K. “Mixed methods assessment

of sexual concurrency in Zambia.” Oral poster presentation at the XVIII International AIDS

Conference (Abstract # TUPDC105), Vienna, Austria, 18-23 July.

2010 MacQueen KM, van Loggerenber F, Weaver M, Succop S, Majola N, Abdool Karim Q, Abdool

Karim S. “Behavioral Recall Accuracy in a Microbicide Trial: Effects of Psychological Stress,

Serostatus and Timing of Interview.” Oral poster presentation at the 2010 International

Microbicides Conference (Abstract # 408), Pittsburgh PA, May 22-25.

2008 MacQueen K. “Anthropology, Bioethics and Community Engagement.” Oral presentation,

Society for Applied Anthropology Meeting, Memphis TN, March 25-29

2006 Guest G, Alleman P, Lawoyin T, Nyiama T, MacQueen K. “Participant experiences of the

tenofovir HIV prevention trial in Nigeria and Cameroon: implications for recruitment and

retention.” Poster presentation at the XVI World AIDS Conference, August 13-18, Toronto,

Canada. MOPE0787.

2006 Mack N, Alleman P, Chaponda M, Bula A, Hoffman I, MacQueen K. “The role of alcohol

consumption in transactional sex in Malawi: a significant factor for HIV prevention intervention

design.” Oral presentation at the XVI World AIDS Conference, August 13-18, Toronto, Canada.

WEAX0404.

Page 11: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 11 Last Rev: 27 September 2016

2006 Mack N, McLoughlin K, Chaponda M, Niyama T, Akumatey B, Lawoyin T, MacQueen K, TDF

Sociobehavioral Research Team. “Perceptions of sexual partnerships, HIV risk, and HIV infection

in Ghana, Nigeria, Cameroon, and Malawi: multiple partners, marriage, and (in)fidelity.” Poster

presentation at the XVI World AIDS Conference, August 13-18, Toronto, Canada. WEPE0770.

2006 Nyiama TA, Mack N, MacQueen K, Guest G, Namey E. “Addressing HIV prevention trial

challenges through sociobehavioral research: Cameroon’s tenofovir trial.” Poster presentation at

the XVI World AIDS Conference, August 13-18, Toronto, Canada. MOPE0792.

2006 Akumatey B, Mack N, Namey E, MacQueen K. “Ethical challenges for HIV prevention trials in

Africa: the cultural meaning of pill-taking and local research literacy in Tema, Ghana.” Poster

presentation at the XVI World AIDS Conference, August 13-18, Toronto, Canada. TUPE0429.

2006 Lawoyin T, Alleman P, Guest G, MacQueen K. “Factors influencing adherence to pills for pre-

exposure prophylaxis: lessons learned from a phase 2 trial.” Poster presentation at the XVI World

AIDS Conference, August 13-18, Toronto, Canada. TUPE0423.

2005 MacQueen KM. “The politics of ethics in HIV prevention research in Africa.” American

Anthropological Association Annual Meeting, November 30 – December 4, Washington DC.

2004 MacQueen KM, Brelsford E, Akumatey B, Lawoyin T, Nyiama T, Guest G. “Ethics

considerations in recruiting women with multiple sex partners into HIV prevention trials in three

West African cities.” Poster presentation at the XV World AIDS Conference, July 11-17,

Bangkok, Thailand

2004 MacQueen KM. “HIV prevention trials: reflections on trying to do right in a world gone wrong.”

Society for Applied Anthropology Annual Meeting, March 31 – April 4, Dallas, TX

2002 MacQueen KM. “Bioethical crosscurrents in health research: anthropological contributions.”

American Anthropological Association Annual Meeting, November 20-24, New Orleans, LA.

2002 MacQueen KM. “Distributive justice and health research: navigating ethical crosscurrents.”

Society for Applied Anthropology Annual Meeting, March 6-9, Atlanta, GA.

2000 MacQueen KM, Bartholow B. “Paving the way for HIV vaccines: interdisciplinary models for

clinical trials and policy development.” Society for Applied Anthropology Annual Meeting,

March 21-26, San Francisco, CA.

1999 MacQueen KM, Kegeles S, Metzger D, Strauss R. “Building community trust in preparation for

HIV vaccine efficacy trials in the U.S.” Society for Community Research and Action 7th Biennial

Conference, June 9-12, Yale University, New Haven, CT.

1998 MacQueen KM, Vanichseni S, Kitayaporn D, Buavirat A, Lin L, Raktham S, Choopanya K,

Naiwatanakul T, Mock P, Des Jarlais D, Heyward W, Mastro T. “Willingness to Participate in an

HIV Vaccine Efficacy Trial Among Injecting Drug users (IDUs) in Bangkok, Thailand.” Poster

presentation at the 12th World AIDS Conference, June 28 – July 3, Geneva, Switzerland

Page 12: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 12 Last Rev: 27 September 2016

1998 MacQueen KM, Blanchard L, McLellan E, Millett G, Metzger D, Kegeles S, Strauss R. “Who Is

‘The Community’ in Community Collaboration?” Poster presentation at the 12th World AIDS

Conference, June 28 – July 3, Geneva, Switzerland

1998 MacQueen KM. “Participatory Models for HIV Prevention Research.” Paper presented at the

conference on Public Health in the 21st Century: Behavioral and Social Science Contributions,

May 7-9, 1998, Atlanta, GA

1997 MacQueen KM, Trotter RT. “Project LinCS: A Multisite Ethnographic Design for Public Health

Research.” Paper presented at the American Anthropological Association Annual Meeting,

November, Washington DC

1996 MacQueen KM, Kay K, Bartholow B, Buchbinder S, McKirnan D, Judson F, Douglas J “The

Relationship Between Perceived Exposure to HIV and Actual Risk in a Cohort of Gay and

Bisexual Men.” Poster presentation at the XI International Conference on AIDS, July 7-12,

Vancouver, BC, Canada

1995 MacQueen KM, Trotter RT, Bartholow B and the CDC HIV Vaccine Studies Team “’If you were

in my place...’: the social context of individual decisions to participate in HIV vaccine trials.”

Paper presented at the American Anthropological Association Annual Meeting, November,

Washington DC

1995 MacQueen KM, Edlin BR, Faruque S, Von Bargen J, Serrano Y and the Multicenter Crack

Cocaine and HIV Infection Study Team. “Geographic networks and HIV prevalence among

young women in the inner city, New York City, 1991-92.” Paper presented at the Third Science

Symposium: HIV Prevention Research, Current Status and Future Directions, August 16-18,

Flagstaff, AZ

1995 MacQueen KM “The significance of social context for the implementation of HIV vaccine

efficacy trials.” Paper presented at the Third Science Symposium: HIV Prevention Research,

Current Status and Future Directions, August 16-18, Flagstaff, AZ

1995 MacQueen KM “The emergence of a social research agenda for community participation in

preparation for HIV vaccine trials.” Paper presented at the Society for Applied Anthropology

Annual Meetings, March 29 - April 2, Albuquerque, NM

1994 MacQueen KM, Buchbinder S, Douglas J, Judson F, McKirnan D, Bartholow B “HIV vaccine

trials and the social significance of immunologic response.” Paper presented at the American

Anthropological Association Annual Meetings, November 30 - December 4, Atlanta, GA

1994 MacQueen KM, Buchbinder S, Douglas J, Judson F, McKirnan DJ, Bartholow B “Required HIV

antibody testing, social harm, and HIV vaccine efficacy trials.” Paper presented at the Conference

on Advances in AIDS Vaccine Development, Seventh National Collaborative Vaccine

Development Group Meeting, November 6-10, Reston, VA

1994 MacQueen KM. “Evaluating the feasibility of conducting vaccine efficacy trials among gay

men.” Paper presented at the Conference on HIV Preventive Vaccines: Social, Ethical, and

Page 13: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 13 Last Rev: 27 September 2016

Political Considerations for Domestic Efficacy Trials, AIDS Action Foundation, May 9-10,

Washington, D.C.

1993 MacQueen KM, S Buchbinder, J Douglas, F Judson, and DJ McKirnan “The decision to enroll in

HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection.”

Paper presented at the Conference on Advances in AIDS Vaccine Development, Sixth National

Collaborative Vaccine Development Group Meeting, October 30 - November 4, Alexandria, VA

1993 MacQueen KM. “Scientific Constraints: Issues in the Design of Large Scale Preventive HIV

Vaccine Trials.” Paper presented at the American Anthropological Association Annual Meetings,

November 17-21, Washington, DC

1991 MacQueen KM. “Parading Identities: Presentations of Self in Saba Carnival.” Paper presented at

the American Anthropological Association Annual Meetings, Nov. 20 - 24, Chicago, IL

1990 MacQueen KM. “Selectivity of migrants by social class in a Caribbean community.” Paper

presented at the American Association of Physical Anthropologists Annual Meeting, April 4-7,

Miami, FL

1986 MacQueen KM. “Household relations in a white West Indian community.” Paper presented at

the American Anthropological Association Annual Meetings, Dec. 3-7, Philadelphia, PA

1986 MacQueen KM. “Sailors, laborers and students: the migrants of Saba, Netherlands Antilles.”

Paper presented at the Northeastern Anthropological Association Annual Meeting, March 20-23,

Buffalo, NY

1985 MacQueen KM. “Migration as a historical process in a Caribbean community.” Paper presented

at the American Anthropological Association Annual Meetings, Dec. 4-8, Washington DC

1983 MacQueen KM. “The effect of loss of estrus on hominid reproductive strategies.” Paper

presented at the American Anthropological Association Annual Meetings, Nov. 16-20, Chicago,

IL

1978 MacQueen KM. “Flexibility in the sexual division of labor in the Circumpolar region.” Paper

presented at the Annual Meeting of the Central States Anthropological Society, Great Bend,

Indiana (as K. M. McGregor)

Page 14: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 14 Last Rev: 27 September 2016

Honors and Awards

2000 Special Act or Service Award, National Center for HIV, STD, and TB Prevention

2000 Performance Award, National Center for HIV, STD, and TB Prevention, CDC

1999 Performance Award, National Center for HIV, STD, and TB Prevention, CDC

1998 Certificate of Appreciation in Recognition of Significant Contributions to the Behavioral

and Social Sciences Working Group and Outstanding Leadership to the Advisory

Subcommittee, BSSWG, CDC

1998 Performance Award, National Center for HIV, STD, and TB Prevention, CDC

1997 Performance Award, National Center for HIV, STD, and TB Prevention, CDC

1996 Performance Award, National Center for HIV, STD, and TB Prevention, CDC

1996 Certificate of Special Recognition for Successfully Working Across Organizational

Boundaries as a Member of the Formalization Committee to Establish the Behavioral and

Social Sciences Working Group, Office of the Director, CDC

1995 Performance Award, National Center for Infectious Diseases, CDC

1994 Performance Award, National Center for Infectious Diseases, CDC

1991-1993 NIMH National Research Service Award, HIV/AIDS Post-Doctoral Training Program

1994-1995 Fulbright-Hays Scholarship

Other Experience and Professional Memberships 1993-2001 CDC Behavioral and Social Science Working Group

1993-94 AIDS Action Foundation Working Group on HIV Preventive Vaccines: Social, Ethical,

and Political Considerations for Domestic Efficacy Trials.

1994-97 American Anthropological Association Commission on AIDS Research and Education.

CDC Liaison.

1994-99 HIV Network for Prevention Trials (HIVNET), NIH/NIAID/DAIDS

Steering Group, 1994-1996

Behavioral Science Direction Group, 1995-1996

Microbicides/Barriers/STDs Science Direction Group, 1995-1996

Vaccine Preparedness Study Full Protocol Team, 1994-1997

Social Harms Working Group, 1996-1997

Community Education and Media Relations Group, 1997-1999

1998-99 Institutional Review Board, CDC Human Subjects Office: Co-chair, 1999

1999 Decisional Impairment Working Group, Department of Health and Human Services.

CDC representative. Interagency group established to review and comment on the

National Bioethics Advisory Commission report on “Research Involving Persons with

Mental Disorders That May Affect Decisionmaking Capacity.”

1999-2001 Vaccine Advisory Group, Vaccine Research Center, Emory University.

2002 ongoing HIV Prevention Trials Network (HPTN) Ethics Working Group

2002-2004 Society for Medical Anthropology, Task Force on Bioethics and Anthropology, Chair.

2002-2012 Fiscal Years 2004-2014 Behavioral and Social Science Planning Group, Office of

AIDS Research, National Institutes of Health

2003 NIH Scientific Review Group, BSPH, ad hoc reviewer

2004 NIH Scientific Review Group, SEP ZRG1 ICP-2 International Bioethics Education &

Development

Page 15: Kathleen M. MacQueen, Ph · 2016-09-29 · 2001-2002 HIV, STD, and TB Public Health Ethics, Practice, and Research: A Workshop and Case Study Review. (CDC project lead) 1999 Phase

Kate MacQueen Page 15 Last Rev: 27 September 2016

2004-2005 Steering Committee, UNAIDS consultations on Ground Rules for HIV Prevention

Trials

2005 NIH Scientific Review Group, SEP for RFA AI 05-002 Units for HIV/AIDS Clinical

Trial Networks

2006-2009 Coalition Advisory Board, Global Health Initiative, Families USA

2006 NIH Scientific Review Group, SEP ZAI1 BLG-A(M1)(2) & Fogarty International

Ethics Training Program

2009 ongoing Editorial Board, Journal of Empirical Research on Human Research Ethics

2009 UNAIDS Expert Panel on Revising the 2000 Guidance Document “Ethical

Considerations in HIV Preventive Vaccine Research”

2009 NIH Scientific Review Group, SEP ZRG1 AARR-F(08); SEP ZRG1 HDM-P(58)R;

SEP ZRG1 IDM-P(50)

2009-2015 UNC-Chapel Hill Center for AIDS Research Internal Advisory Boards for the Clinical

Core and Social & Behavioral Science Research Core

2010 ongoing Editorial Board, Journal of the International AIDS Society

2010-2011 Planning Committee, 1st International HIV Social Science and Humanities

Conference, 11-13 June 2011, Durban, South Africa

2011-2015 Founding member, Association for the Social Sciences and Humanities in HIV

2011 ACTG-HPTN Inter-network Scientific Committee

2012 Planning Committee, 2nd International HIV Social Science and Humanities

Conference, 7-10 July 2013, Paris, France

2012 Behavioral and Social Science Approaches to Preventing HIV/AIDS Study Section

(BSPH), NIH, ad hoc member19-20 March

2013 External portfolio review of the trans-NIH AIDS-related behavioral and social science

research program

2014-2018 Behavioral and Social Science Approaches to Preventing HIV/AIDS Study Section

(BSPH), Center for Scientific Review, NIH